Alpha Tau Medical (DRTS) | Stock Overview & Key Data

Alpha Tau Medical Ltd. | Healthcare

$3.02

7.47%

| Alpha Tau Medical Stock Comparison:

Alpha Tau Medical vs Vertex Alpha Tau Medical vs Regeneron Alpha Tau Medical vs Cartesian Alpha Tau Medical vs Foghorn Therapeutics Alpha Tau Medical vs Tevogen Bio Holdings Alpha Tau Medical vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Alpha Tau Medical Performance Comparison

Loading chart data...

Alpha Tau Medical

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $2.82 High: $3.14

on June 7, 2025

52 Week Range

Low: $1.75 High: $4.39

on June 27, 2024

on January 27, 2025

All-Time High: $20.65 on March 21, 2022

Key Statistics

Market Cap i $249.0M

EPS i -0.45

P/E Ratio (TTM) i N/A

Forward P/E i -6.00

P/B Ratio i 3.30

PEG Ratio i -6.00

Div. Yield i 0.00%

ROE i -47.95%

Beta i N/A

Debt to Equity i 21.83

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 0.00%

Profit Margin i 0.00%

Returns and Earnings

Return on Assets (TTM) i -25.17%

Return on Equity (TTM) i -47.95%

EBITDA i $-35.8M

Net Income (TTM) i $-32.5M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i N/A

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Alpha Tau Medical DRTS	249.02M Micro-cap	1.34%	16.60%	7.47%	0.67%	-2.58%	23.77%	-68.74%	-69.15%
Vertex VRTX	113.97B Large-cap	1.91%	0.10%	-7.25%	-2.51%	11.03%	-6.74%	76.75%	67.75%
Regeneron REGN	52.15B Large-cap	0.60%	-11.69%	-29.38%	-36.60%	-31.04%	-50.82%	-13.74%	-16.17%
Cartesian RNAC	247.60M Micro-cap	15.38%	4.35%	-38.21%	-56.13%	-34.85%	-69.85%	-67.75%	-86.28%
Foghorn Therapeutics FHTX	243.03M Micro-cap	9.31%	12.06%	-0.89%	-32.12%	-2.83%	-25.79%	-67.45%	-75.39%
Tevogen Bio Holdings TVGN	239.06M Micro-cap	10.85%	36.19%	30.00%	26.55%	34.91%	72.29%	-69.25%	-69.25%

Ownership & Short Interest

Insider Ownership i 32.92%

Institutional Ownership i 1.80%

Shares Short i 111K

Short Ratio i 3.42

Short % of Shares Outstanding i 0.17%

Average 10-Day Volume i 48K

Average 90-Day Volume i 47K

Alpha Tau Medical Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Alpha Tau Medical would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is DRTS's 52-week high and low?

In the last 52 weeks, Alpha Tau Medical reached a high of $4.39 (on January 27, 2025) and a low of $1.75 (on June 27, 2024).

What is the market cap and P/E ratio for DRTS?

Curious about Alpha Tau Medical's size and valuation? Its market capitalization stands at 249.02M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -6.00.

Does DRTS pay dividends? If so, what's the yield?

As for dividends, Alpha Tau Medical isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Alpha Tau Medical's main competitors or similar companies to consider before investing?

When looking at Alpha Tau Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	113.97B	Healthcare	Biotechnology	-6.74%	76.75%
Regeneron REGN	52.15B	Healthcare	Biotechnology	-50.82%	-13.74%
Cartesian RNAC	247.60M	Healthcare	Biotechnology	-69.85%	-67.75%
Foghorn Therapeutics FHTX	243.03M	Healthcare	Biotechnology	-25.79%	-67.45%
Tevogen Bio Holdings TVGN	239.06M	Healthcare	Biotechnology	72.29%	-69.25%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Alpha Tau Medical Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Alpha Tau Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -47.95%, the Debt to Equity ratio from the most recent quarter is 21.83, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for DRTS?

Looking at Alpha Tau Medical's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of DRTS stock is held by insiders and institutions?

Wondering who owns Alpha Tau Medical stock? Company insiders (like executives and directors) hold about 32.92% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.80%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.